A Mark Cuban copy? Cigna’s Express Scripts to offer what it calls another cost-plus pricing model

Cigna Group is go­ing to sell pre­scrip­tion drugs for a markup in a mod­el that’s sim­i­lar to bil­lion­aire Mark Cuban’s Cost Plus Drug Com­pa­ny, but at a greater scale.

Start­ing in ear­ly 2024, Cigna’s phar­ma­cy ben­e­fit man­age­ment sub­sidiary Ex­press Scripts — which con­trols about one-quar­ter of the PBM mar­ket — will of­fer em­ploy­ers, gov­ern­ment or­ga­ni­za­tions and health plans the choice to pay up to 15% above whole­sale costs plus a flat phar­ma­cy dis­pens­ing fee for drugs, the com­pa­ny said in a press re­lease Tues­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.